National Institute of Allergy and Infectious Diseases
Grantee website Bethesda, Maryland, United StatesPurpose
to fund pre-clinical testing and development of monoclonal antibody based nucleic-acid based vaccine for influenza A virus
Grantee
Division
Global Health
Date
OCTOBER 2018
Region served
GLOBAL
Committed amount
$275,500
Grant topic
Create Novel Technology Platform Capabilities
Duration (months)
21
Grantee location
Bethesda, Maryland, United States
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.